Publication | Open Access
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir
11
Citations
34
References
2024
Year
NCT04280705 (ClinicalTrials.gov).
| Year | Citations | |
|---|---|---|
Page 1
Page 1